In 2006, life expectancy for males in Cyprus was 79 and for females 82 years.  Infant mortality in 2002 was 5 per 1,000 live births, comparing favourably to most developed nations.  A systematic population analysis of deaths in the adult population (ages 15–59) and released in 2010 in The Lancet place Cyprus as the country with the lowest mortality in females and 14th lowest mortality in males.   The three most common causes of death are circulatory disease, neoplasms, and respiratory disease.  The two most common cancers are prostate cancer and breast cancer.  The measles immunisation rate of 86% for one year olds is below the WHO European region average rate and second lowest in the EU.   As of 2013, life expectancy for females was 85 and for males 80. Infant mortality in 2002 was 5 per 1,000 live births, comparing favourably to most developed nations.   A systematic population analysis of deaths in the adult population (ages 15–59) and released in 2010 in The Lancet, place Cyprus as the country with the lowest mortality for females and 14th lowest mortality for males.   In 2015 it was estimated that 10.2% of the population has diabetes, costing about $2,295 per person per year.  Smoking rates in Cyprus are considered high by international standards. WHO Statistics from 1998 show that 38.5% of males were smokers.  Healthcare in Cyprus 